A 12-year study (1975-1986) of mortality in methadone-maintenance patients: Selected demographic characteristics and drug-use patterns of AIDS and non-AIDS-related deaths

Substance Use and Misuse

Volumn 33, Issue 12, 1998, Pages 2521-2534

  Petry, Nancy M ^a,c   Bickel, Warren K ^b   Badger, Gary J ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Cocaine; Heroin; Methadone maintenance; Mortality; Polydrug use(rs)

Indexed keywords

CENTRAL STIMULANT AGENT; METHADONE; OPIATE DERIVATIVE; QUININE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; UNITED STATES;

EID: 0031688563     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.3109/10826089809059339     Document Type: Article

References (31)

1. BALL, J. C., LANGE, W. R., MYERS, C. P., and FRIEDMAN, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. J. Health Soc. Behav. 29: 214-226.
2. BALL, J. C., and ROSS, A. (1991). The Effectiveness of Methadone Maintenance Treatment. New York, NY: Springer-Verlag.
3. BICKEL, W. K., and AMASS, L. (1993). The relationship of mean daily blood alcohol levels to admission MAST, clinic absenteeism, and depression in alcoholic methadone patients. Drug Alcohol Depend. 32: 113-118.
4. BRETTLE, R. (1991). HIV and harm reduction for injection drug users. AIDS 5: 125-136.
5. CHERUBIN, C. (1967). The medical sequelae of narcotic addiction. Ann. Intern. Med. 67: 23-33.
6. CHERUBIN, C., MCCUSKER, J., BADEN, M., KAVALER, F., and AMSEL, Z. (1972). The epidemiology of death in narcotic addicts. Am. J. Epidemiol. 96: 11-22.
7. CONCOOL, B., SMITH, H., and STIMMEL, B. (1979). Mortality rates of persons entering methadone maintenance: A seven year study. Am. J Drug Alcohol Abuse 6: 345-353.
8. COOPER, J. R. (1989). Methadone treatment and acquired immunodeficiency syndrome. JAMA 262: 1664-1668.
9. CROUGHAN, J. L., MILLER, J. P., WHITMAN, B. Y., and SCHROBER, J. G. (1981). Alcoholism and alcohol dependence in narcotic addicts: A prospective study with a 5-year follow-up. Am. J. Drug Alcohol Abuse 8: 85-94.
10. DES JARLAIS, D. C., FRIEDMAN, S. R., NOVICK, D. M., et al. (1989). HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 261: 1008-1112.
11. DOLE, V. P. (1989). Methadone treatment and acquired immunodeficiency syndrome epidemic. JAMA 262: 1681-1682.
12. DRUCKER, E. (1986). AIDS and addiction in New York City. Am. J. Drug Alcohol Abuse 12: 165-181.
13. DRUCKER, E., WEBBER, M., MCMASTER, P., and VERMUND, S. H. (1989). Increasing rate of pneumonia hospitalization in the Bronx: A sentinel indicator for human immunodeficiency virus. Int. J. Epidmiol. 18: 926-933.
14. HARDY, A. R., ALLEN, J. R., MORGAN, W. M., and CURRAN, J. W. (1985). The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA 253: 215-220.
15. HECKMANN, W., and SOELLNER, R. (1991). Federal Republic of Germany: A dramatic increase in drug-related deaths. In National Institute on Drug Abuse (NIDA), Epidemiologic Trends in Drug Use. Proceedings of the Community Epidemiology Work Group [DHHS Publication (ADM) 92, pp. 371-389]. Rockville, MD: NIDA.
16. HELPERN, M. (1975). Fatalities from narcotic addiction in New York City. Hum. Pathol. 3: 13-21.
17. HELPERN, M., and RHO, Y. M. (1966). Deaths from narcotism in New York City. N. Y. State J. of Med. 66: 2391-2408.
18. HUBBARD, R., MARSDEN, M. E., CAVANAUGH, E., et al. (1988). Role of drug abuse treatment in limiting the spread of AIDS. Rev. Infect. Dis. 10: 377-384.
19. JOE, G. W., LEHMAN, W., and SIMPSON, D. D. (1982). Addict death rates during a four-year posttreatment follow-up. Am. J. Public Health 72: 703-709.
20. JOSEPH, H., and APPEL, P. (1985). Alcoholism and methadone treatment: Consequences for the patient and the program. Am. J. Drug Alcohol Abuse 11: 37-53.
21. KREEK, M. J. (1978). Medical complications in methadone patients. Ann. N.Y. Acad. Sci. 311: 110-134.
22. KRINGSHOLM, B. (1988). Deaths among drug addicts in Denmark in 1968-1986. Forensic Sci. Int. 38: 139-149.
23. KRISTAL, A. R. (1986). The impact of the acquired immunodeficiency syndrome on patterns of premature deaths in New York City. JAMA 255: 2306-2310.
24. MCCLUSKEY-CAVIN, H., and BOURQUIN, M. (1992). Multi-city Study of Drug Misuse. 1991 Update of Data. Geneva Report. Strasbourg: Pompidou Group, Council of Europe.
25. POLLOCK, D. A., HOLMGREEN, P., LUI, K. J., and KIRK, M. L. (1991). Discrepancies in the reported frequency of cocaine-related deaths, United States, 1983 through 1988. JAMA 266: 2233-2237.
26. SELWYN, P. A. (1991). Injection drug use, mortality and AIDS epidemic. Am. J. Public Health 81: 1247-1249.
27. SELWYN, P. A., HARTEL, D., WASSERMAN, W., and DRUCKER, E. (1989). Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am. J. Public Health 79: 1358-1362.
28. STONEBURNER, R. L., DES JARLAIS, D. C., BENEZRA, D., et al. (1988). A larger spectrum of severe HIV-1-related disease in intravenous drug users in New York City. Science 242: 916-919.
29. WATTERSON, O., SIMPSON, D. D., and SELLS, S. B. (1975). Death rates and causes of death among opiate addicts in community drug treatment programs 1970-1973. Am. J. Drug Alcohol Abuse 2: 99-111.
30. WEBER, R., LEDERGERBER, B., OPRAVIL, M., et al. (1990). Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J. 301: 1362-1365.
31. WEINBERG, D. S., and MURRAY, H. W. (1987). Coping with AIDS: The special problem of New York City. New Engl. J. Med. 317: 1469-1473.